Ticker Symbol: EIGR
Eiger BioPharmaceuticals Inc
$7.82 - 17-09-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001305253
Company Profile
Eiger is a commercial-stage biopharmaceutical company focused on the development and commercialization of foundational therapies for Hepatitis Delta Virus (HDV) infection, the most serious form of human viral hepatitis.
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 2155 Park Blvd
Website: www.eigerbio.com
CEO: David Cory
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.29
Change:
$0.00
(
-2.68%)
Days Range: $0.25 - $0.29
Beta: 1.06
52wk. High: $5.51
52wk. Low: $0.23
Ytd. Change -77.34%
50 Day Moving Average: $0.39
200 Day Moving Average: $0.78
Shares Outstanding: 44296417
Valuation
Market Cap: 1.3B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A